TOPLINE:One of the first studies of its kind finds that inadvertent exposure during early pregnancy to glucagon-like peptide 1 receptor agonists (GLP1-RAs) is not associated with major birth defects or pregnancy loss.METHODOLOGY:This study was a multicentre prospective cohort study of three groups of pregnant women who contacted, or whose physician contacted, any of six European ..read more

While there were no notable mega-mergers in the ASC industry in 2023, there was transaction activity by multi-site operators and health systems, according to VMG Health's 2024 Healthcare M&A Report published May 7. Here are the seven ASC deals to know in 2023, according to the report. 1. In February 2023, United Musculoskeletal Partners partnered ..read more

Here are five of the many physicians on the cutting edge of gastroenterology who have recently made headlines:If you would like to nominate a physician, please email pnewitt@beckershealthcare.comJustin Forde, MD. Dr. Forde, an advanced endoscopist at Lawrenceville, Ga.-based Northside Hospital Gwinnett, is a part of a recent expansion of the hospitals' interventional gastrointestinal program. The ..read more

Treatment plans are crucial to a behavioral health practice as they can help improve client outcomes. Setting mental health treatment plan goals and objectives is a crucial aspect of the process, and providers and their clients need to work together in identifying long-term therapy goals. They should also communicate openly about the objectives used to ..read more

Talkspace Inc. (Nasdaq: TALK) continues to thin its financial losses as it grows its payer- and government-focused business lines. The once direct-to-consumer, texting-based digital therapy company continues to move closer to profitability. On an adjusted basis, earnings totaled about $774,000. This is the first profitable quarter since the company’s IPO in 2021. Its net loss ..read more

Lykos Therapeutics’ MDMA-assisted therapy is charting yet another first in the psychedelic field: an FDA advisory meeting. The biotech will meet with the Psychopharmacologic Drugs Advisory Committee on June 4, according to a late Monday release. This will be the first time that FDA experts will formally debate a psychedelic treatment. Lykos (formerly known as ..read more

In this video, 4 experts discuss the highlights and take-home messages from the 2024 American Urological Association Annual Meeting.In this video, Matthew Nielsen, MD, MS, FACS; Jay Simhan, MD, FACS; Sarah P. Psutka, MD, MSc; and Joshua Meeks, MD, PhD discuss the highlights and take-home messages from the 2024 American Urological Association Annual Meeting, which ..read more

The company has treated the first patient in an early trial of its cholesterol treatment Verve-102, a successor to its former lead candidate.Dive Brief:Verve Therapeutics has treated the first participant in a recently begun clinical trial of the company’s backup gene editing therapy for heart disease, about one month after a safety setback derailed what ..read more

A majority of young adults say they would not live in a state that has banned abortion, according to a survey released Tuesday.In the CNBC/Generation Lab poll of 1,033 adults ages 18-34, a total of 62 percent said they would “probably not” (32 percent) or “definitely not” (30 percent) live in a state that bans ..read more

Laura T. Safar, MD, led a discussion on the prevalence and prevention of violence in the workplace.CONFERENCE REPORTERWorkplace violence is on the rise in all health care settings, Laura T. Safar, MD, told attendees at the 2024 American Psychiatric Association Annual Meeting.1 According to Safar between 50% and 90% of health care workers have been ..read more